Key result
Four cardiometabolic risk factors linked to ~3-fold higher MACE risk versus zero factors.
Why the study?
Does a greater cumulative burden of cardiometabolic risk factors increase the risk of major adverse cardiovascular events and mortality in Chinese adults without baseline cardiovascular disease?
Cohort (n=98,373)
Does a greater cumulative burden of cardiometabolic risk factors increase the risk of major adverse cardiovascular events and mortality in Chinese adults without baseline cardiovascular disease?
Hazard Ratio: 2.92 (95% CI 2.69–3.16)
Absolute Event Rate: 65.8% vs 13.3%
p-value: p=<0.001
A higher cumulative burden of cardiometabolic risk factors strongly and dose-dependently increases the risk of future major cardiovascular events and mortality, highlighting the clinical necessity of integrated, multi-risk preventive strategies.
The rising prevalence of cardiometabolic risk factors in China poses a significant public health challenge. This study aimed to evaluate the prevalence and clustering of hypertension, diabetes, dyslipidemia, and overweight/obesity, and their associations with major adverse cardiovascular events (MACE) and all-cause mortality. We analyzed 98,373 adults (mean age 54.2 years; 60.7% female) without baseline cardiovascular disease (CVD) from the Guangdong sub-cohort of the China PEACE Million Persons Project (2016–2020). Participants were categorized by the number of cardiometabolic risk factors (0 to 4). Cox proportional hazards models were used to estimate hazard ratios (HRs) for MACE (a composite of myocardial infarction, coronary heart disease, heart failure, stroke, and cardiovascular death) and all-cause mortality. Only 23.5% of participants were free of all four risk factors, while 18.5% possessed three or more. Overweight/obesity (49.3%), hypertension (39.7%), and dyslipidemia (39.3%) were the most prevalent. Over a median follow-up of 5.02 years (IQR, 4.11–5.84; 481,162 person-years), compared to the 0-risk-factor group, the fully adjusted HRs for MACE were 1.37 (95% CI 1.29–1.47), 1.70 (1.60–1.81), 2.21 (2.07–2.36), and 2.92 (2.69–3.16) for participants with 1, 2, 3, and 4 risk factors, respectively (P-trend < 0.001). Similar dose–response relationships were found for all-cause mortality and individual CVD components, with the strongest association observed for heart failure (HR 4.01 for 4 factors). Cardiometabolic risk factors are highly prevalent and frequently clustered in southern Chinese adults. Greater cardiometabolic risk factor burden is significantly associated with future MACE and mortality, highlighting the need for integrated, multi-modal preventive strategies in community settings.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) conducted a cohort in No baseline cardiovascular disease (n=98,373). Cumulative cardiometabolic risk factors (hypertension, diabetes, dyslipidemia, overweight/obesity) vs. Zero cardiometabolic risk factors was evaluated on Major adverse cardiovascular events (composite of myocardial infarction, coronary heart disease, heart failure, stroke, and cardiovascular death) (HR 2.92, 95% CI 2.69-3.16, p=<0.001). The presence of four cardiometabolic risk factors increased the risk of major adverse cardiovascular events by nearly three-fold compared to having zero risk factors (HR 2.92, 95% CI 2.69-3.16, P-trend < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: